Tak Hang Chan

Title: Innovations of Tak Hang Chan in Cancer Research

Introduction

Tak Hang Chan is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer research, particularly in the development of novel compounds aimed at overcoming multidrug resistance in cancer therapies. With a total of 2 patents, his work is recognized for its potential impact on improving treatment outcomes for cancer patients.

Latest Patents

One of Tak Hang Chan's latest patents focuses on alkyne-, azide-, and triazole-containing flavonoids as modulators for multidrug resistance in cancers. This innovative research led to the construction of a triazole bridged flavonoid dimer compound library through the cycloaddition reaction of flavonoid-containing azides and alkynes. The resulting compounds were screened for their ability to modulate multidrug resistance in various cancer cell lines, including those overexpressing P-glycoprotein (P-gp), MRP1, and BCRP transporters. The findings revealed promising MDR reversal activity, with compounds demonstrating varying selectivity for different transporters. Notably, some compounds exhibited EC50 values at or below 10 nM in BCRP-overexpressed cell lines, indicating their potential as selective inhibitors. Most of the dimers were found to be safe MDR chemosensitizers, as evidenced by their high therapeutic index values.

Career Highlights

Throughout his career, Tak Hang Chan has been associated with esteemed institutions such as The Hong Kong Polytechnic University and McGill University. His research has contributed to advancing the understanding of drug resistance mechanisms in cancer, paving the way for the development of more effective therapeutic strategies.

Collaborations

Tak Hang Chan has collaborated with notable colleagues, including Larry Ming Cheung Chow and Kin Fai Chan. These partnerships have further enriched his research endeavors and expanded the scope of his innovative work.

Conclusion

Tak Hang Chan's contributions to cancer research through his innovative patents and collaborations highlight his commitment to addressing critical challenges in the field. His work continues to inspire advancements in the fight against cancer and the development of effective treatment options.